Clinical Trial Shows Chewing Gum Reverses COVID-Related Sensory Loss

This breakthrough demonstrates that COVID-related sensory loss, which affects millions of long-COVID patients, may be reversible through targeted sensory rehabilitation therapy. The University of Nottingham's decentralized clinical trial found that specially formulated chewing gums restored taste and smell in 67% and 83% of participants respectively within 12 weeks. For patients previously resigned to permanent loss of smell and taste, this research offers hope that post-viral sensory dysfunction can be treated effectively.